Macular Degeneration Foundation

Macular Degeneration Foundation Macular Degeneration Foundation MDF was founded as a 501c3 tax-exempt charitable medical research an We fund research grants through universities.

Macular Degeneration Foundation (MDF) was founded as a 501c3 tax-exempt charitable medical research and educational foundation dedicated to:

"Support”
It is our mission to be a personal contact by providing toll-free phone lines that patients can call to receive free information about Macular Degeneration, the treatments, and resources available to make coping with this disease a little easier. We work in cooperation with and provide support grants to other organizations to set up local low vision support groups, and provide Comcast for interactive education for groups. "Research to Restore Vision"
We interview researchers and investigate all new prospective treatments and clinical trials. In addition to the support of long-term efforts in the fields of Stem Cell and Genetic research for an ultimate cure, we are particularly interested in promising near-term, scientific studies designed to inhibit the progression of macular degeneration and restore a measurable amount of vision to all. In the past we have funded grants through NIH, University of Arizona, Pacific University Oregon, Harvard, and UC Davis. "People Helping People"
As Macular Degeneration effects mostly an older generation on fixed income, we have established this branch of our organization for direct support for people in need. We have begun a “recycle” program for magnifiers and low vision devices. As machines are no longer needed, they can be donated to our foundation. We pay for the shipping so the donor is not inconvenienced. We are establishing relationships with low vision centers that can screen patients for need of financial aid, matching them with the best machines, and providing the patient with training on the machine.

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperime...
10/01/2024

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trial
Dun Jack "DJ" Fu, BM B*h, PhD
Moorfields Eye Hospital, University College London
Kings College London
Phone: +44 20 7253 3411
https://profiles.ucl.ac.uk/91906-dun-jack-fu
https://www.moorfields.nhs.uk/

https://macularnews.org/2024/09/30/arvo-2024-dun-jack-fu-phd/

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trial Dun Jack “DJ” Fu, BM B*h, PhD Moor…

AREDS Vitamin Formula and Nutrition for Slowing Progression of AMDCongratulations on winning the 2024 Proctor's Medal!Em...
10/01/2024

AREDS Vitamin Formula and Nutrition for Slowing Progression of AMD
Congratulations on winning the 2024 Proctor's Medal!
Emily Y. Chew, M.D.
NIH Distinguished Investigator
DECA - Clinical Trials Branch
National Eye Institute
10 Center Drive,
Bethesda, MD-20892
301-496-6583
https://irp.nih.gov/

https://macularnews.org/2024/09/30/arvo-2024-emily-y-chew-m-d/

AREDS Vitamin Formula Study Results After 10 years Emily Y. Chew, M.D. NIH Distinguished Investigator DECA Clinical Trials Branch National Eye Institute 10 Center Drive, Bethesda, MD-20892 301-496-…

Bruch's Membrane Calcification in Pseudoxanthoma  Elasticum:   Comparing Histopathology and Clinical Imaginghttps://macu...
09/25/2024

Bruch's Membrane Calcification in Pseudoxanthoma Elasticum: Comparing Histopathology and Clinical Imaging
https://macularnews.org/2024/09/22/arvo-2024-richard-b-thompson-phd/
Richard B. Thompson, PhD
University of Maryland
and
Dr. Imre Lengyel
Queen's University Belfast

Richard B. Thompson, PhDUniversity of Maryland School of Medicine Dr. Imre LengyelQueen’s University Belfast Bruch’s Membrane Calcification in Pseudoxanthoma Elasticum: Comparing Histop…

https://macularnews.org/2024/09/17/arvo-2024-samuel-barone-md/MCO-020 Gene Therapy for Macular Degeneration and GA Samue...
09/25/2024

https://macularnews.org/2024/09/17/arvo-2024-samuel-barone-md/
MCO-020 Gene Therapy for Macular Degeneration and GA
Samuel Barone, MD
Chief Medical Officer
Nanoscope Therapeutics
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186

Samuel Barone, MDChief Medical OfficerNanoscope Therapeutics, Inc.Trinity Towers2777 N. Stemmons Fwy.Dallas, TX 75207(817) 857-1186 MCO-020 Gene Therapy for Macular Degeneration and GA

LumiThera - Photobiomodulation Light Therapy for IntermediateDry Macular Degeneration LIGHTSITE Trial Clark Tedford, PhD...
09/25/2024

LumiThera - Photobiomodulation Light Therapy for Intermediate
Dry Macular Degeneration LIGHTSITE Trial
Clark Tedford, PhD, President & CEO
LumiThera
https://macularnews.org/2024/09/07/arvo-2024-clark-tedford-phd/

Clark Tedford, PhDPresentation: LumiThera – Photobiomodulation light therapy for dry amd

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperime...
09/24/2024

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trial
Dun Jack "DJ" Fu, BM B*h, PhD
Moorfields Eye Hospital, University College London
Kings College London
Phone: +44 20 7253 3411
https://profiles.ucl.ac.uk/91906-dun-jack-fu
https://www.moorfields.nhs.uk/

https://youtu.be/a1ArvcTHGKI

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trialDun Jac...

Long-term efficacy and safety of pegcetacoplan over 36 months including 12-month results of the GALE open-label extensio...
09/23/2024

Long-term efficacy and safety of pegcetacoplan over
36 months including 12-month results of the GALE
open-label extension study
Ashkan M. Abbey, MD, FASRS, FAAO
Texas Retina Associates
Address: 10740 N Central Expy, Dallas, TX 75231
Phone: (800) 695-6941
https://www.texasretina.com/

https://macularnews.org/2024/09/07/arvo-2024-ashkan-m-abbey-md/

Ashkan M. Abbey, MD, FASRS, FAAO Presentation: Long-term efficacy and safety of pegcetacoplan over 36 months including 12-month results of the GALE open-label extension study

Genetic link of eye diseases  in multi-generational African FamiliesKaren Allison, M.D., M.B.A.University of RochesterUn...
09/23/2024

Genetic link of eye diseases in multi-generational African Families
Karen Allison, M.D., M.B.A.
University of Rochester
University of Rochester Flaum Eye Institute
https://macularnews.org/2024/09/07/arvo-2024-karen-allison-md-2/

Karen Allison, MDPresentation: Genetic link of eye diseases in multi-generational African Families

Positive Top-line Results from Randomized Controlled Trials of MCO-010 Gene Therapy for RP and StargardtSamuel Barone, M...
09/23/2024

Positive Top-line Results from Randomized Controlled Trials of MCO-010 Gene Therapy for RP and Stargardt
Samuel Barone, MD, Chief Medical Officer
Nanoscope Therapeutics
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186

Samuel Barone, MDChief Medical OfficerNanoscope Therapeutics, Inc.Trinity Towers2777 N. Stemmons Fwy.Dallas, TX 75207(817) 857-1186 Positive Top-line Results fromRandomized Controlled Trials of MCO…

We feel that this could be a life changer for people with vision loss due to macular degeneration.  It is a wearable tha...
09/20/2024

We feel that this could be a life changer for people with vision loss due to macular degeneration. It is a wearable that you don't have to take off. It incorporates with your normal vision. They offer a loaner program and financing as well.
eSight Go by Gentex
New Version of Vision Enhancing Wearable Assistive Technology Device
Roland Mattern, Director of Sales
Gary Foster, eSight Advocate and User since 2015
https://www.esighteyewear.com/

https://macularnews.org/2024/09/07/arvo-2024-roland-mattern/

Roland Mattern, Director of Sales – eSight Presentation: eSight Go by Gentex New Version of Vision Enhancing Wearable Assistive Technology Device

Treefa Shwani is a PhD student in Dr. Meg DeAngelis' Lab at Jacob's School of Medicine.  This is also part of a grant we...
09/20/2024

Treefa Shwani is a PhD student in Dr. Meg DeAngelis' Lab at Jacob's School of Medicine. This is also part of a grant we funded.
Decoding Genome-wide miRNA Signatures in Human Donor Eye Tissue Across Early and Late Stages of Dry AMD
Treefa Shwani. PhD Program
University at Buffalo
Jacobs School of Medicine & Biomedical Sciences - University at Buffalo
Margaret DeAngelis PhD Lab
Department of Ophthalmology
https://medicine.buffalo.edu/

https://macularnews.org/2024/09/07/arvo-2024-treefa-shwani/

Treefa Shwani, PhD studentPresentation: Decoding Genome-wide miRNA Signatures in Human Donor Eye Tissue Across Early and Late Stages of Dry AMD

Dr. Zhang works in Prof. Meg DeAngelis' Lab.  He presented on findings for a project that we provided funding for.Genome...
09/20/2024

Dr. Zhang works in Prof. Meg DeAngelis' Lab. He presented on findings for a project that we provided funding for.
Genome-wide Pleiotropy Analysis of AMD and Late-Onset Alzheimer's Disease Reveals Shared Genetic Architecture in the Complement Pathway
Charles Zhang, M.D.
University at Buffalo
Jacobs School of Medicine & Biomedical Sciences - University at Buffalo

Charles Zhang, M.D.SUNY BuffaloJacob’s School of Medicine & Biomedical Sciences Genome-wide Pleiotropy Analysis of AMD andLate-Onset Alzheimer’s Disease Reveals SharedGenetic Archit…

Address

Henderson, NV

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Macular Degeneration Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram